COVID-19 or systemic lupus erythematosus: Attention to similarity
References
- Herman C, Mayer K, Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology. 2020;95(2):77-84. DOI: 10.1212/WNL.0000000000009673
- Misra DP, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin rheumatol. 2020;39(7):2055-62. DOI: 10.1007/s10067-020-05073-9
- Garg Y, Kakria N, Singh S, Jindal AK. Coronavirus disease-19 triggered systemic lupus erythematous: A novel entity. Lung India: Official Organ of Indian Chest Society. 2023;40(1):79. DOI: 10.4103/lungindia.lungindia_494_21
- Danchenko N, Satia J, Anthony M. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308-18. DOI: 10.1191/0961203306lu2305xx
- Sène D, Piette J-C, Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun rev. 2008;7(4):272-7. DOI: 10.1016/j.autrev.2007.10.001
- Aringer M, Costenbader KH, Dörner T, Johnson SR. Gastrointestinal SLE involvement in SLE classification. Response to: “2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringer et al” by Cui et al. Annals of the Rheumatic Diseases. 2020. DOI: 10.1136/annrheumdis-2020-218615
- Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 Feb;4(2):295-306. DOI: 10.1111/j.1538-7836.2006.01753.x
- Kouranloo K, Dey M, Elwell H, Nune A. A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. Rheumatol int. 2023:1-23. DOI: 10.1007/s00296-023-05283-9
- Wucherpfennig KW. Structural basis of molecular mimicry. J autoimmun. 2001;16(3):293-302. DOI: 10.1006/jaut.2000.0499
- Vahabi M, Ghazanfari T, Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int Immunopharmacol. 2022:109183. DOI: 10.1016/j.intimp.2022.109183
- Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine. 2008;87(6):311-8. DOI: 10.1097/MD.0b013e31818ec711
- Regner M, Lambert P-H. Autoimmunity through infection or immunization? Nature immunol. 2001;2(3):185-8. DOI: 10.1038/85228
- Uthman IW, Gharavi AE, editors. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum. 2002 Feb;31(4):256-63. DOI: 10.1053/sarh.2002.28303
- Homa T, Abrahim S, Uzma H, Adler B, Law G, Kirthi M, et al. Fevers in Adult Lupus Patients. Cureus. 2018;10(1).
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis rheumatol. 2019;71(9):1400-12. DOI: 10.1002/art.40930
- Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. New England J Med. 2002;346(10):752-63. DOI: 10.1056/NEJMra002974
- Asherson R, Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis. 2003 May;62(5):388-393. DOI: 10.1136/ard.62.5.388
- Vila P, Hernandez M, Lopez-Fernandez M, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost. 1994 Aug;72(2):209-13. DOI: 10.1055/s-0038-1648840
- Pineton de Chambrun M, Frere C, Miyara M, Amoura Z, Martin-Toutain I, Mathian A, Hekimian G, Combes A. High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? J Intern Med. 2021 Mar;289(3):422-424. DOI: 10.1111/joim.13126
- Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40. DOI: 10.1182/blood.2020006000
- Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):889-891. DOI: 10.1136/jnnp-2020-323586
- Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):e38. DOI: 10.1056/NEJMc2007575
- Gemcioglu E, Erden A, Davutoglu M, Karabuga B, Kucuksahin O. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19. J Clin Rheumatol. 2020 Sep;26(6):236-237. DOI: 10.1097/RHU.0000000000001565
Language: English
Page range: 59 - 64
Submitted on: May 31, 2024
Accepted on: Dec 5, 2024
Published on: Feb 6, 2025
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2025 Abdulsamet Erden, Özlem Karakaş, Bahar Özdemir Ulusoy, Emin Gemcioğlu, Seval İzdeş, Rahmet Güner, Handan Yarkan, Fatma Erden, Ahmet Omma, Orhan Küçükşahin, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.